DNAnexus

OverviewSuggest Edit

DNAnexus is a company that develops a biomedical informatics and data management platform that allows analyzing DNA-sequencing data. Its platform helps researchers to accelerate their genomics programs, as well as allows academic medical researchers to visualize and analyze big data system for DNA from a single, unified system.
TypePrivate
Founded2009
HQMountain View, CA, US
Websitednanexus.com
Employee Ratings4.7
Overall CultureD+

Latest Updates

Employees (est.) (Sept 2021)187
Job Openings25
Cybersecurity ratingAMore

Key People/Management at DNAnexus

Richard Daly

Richard Daly

CEO
George Asimenos

George Asimenos

Chief Technology Officer
Julie Baher

Julie Baher

VP, Customer Experience
Sean Bennett

Sean Bennett

VP of Sales, Pharmaceuticals
Dante Corricello

Dante Corricello

VP and Head of Legal
Omar Serang

Omar Serang

Chief Cloud Officer
Show more

DNAnexus Office Locations

DNAnexus has offices in Mountain View, Boston, San Francisco and Washington
Mountain View, CA, US (HQ)
1975 W El Camino Real
Boston, MA, US
Boston, MA, USA
San Francisco, CA, US
703 Market St #2100, San Francisco
Washington, DC, US
Washington, DC, USA
Show all (4)

DNAnexus Financials and Metrics

Summary Metrics

Founding Date

2009

DNAnexus total Funding

$272.6 m

DNAnexus latest funding size

$100 m

Time since last funding

a year ago

DNAnexus investors

DNAnexus's latest funding round in June 2020 was reported to be $100 m. In total, DNAnexus has raised $272.6 m
Show all financial metrics

DNAnexus Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

DNAnexus Online and Social Media Presence

Embed Graph

DNAnexus Company Culture

  • Overall Culture

    D+

    65/100

  • CEO Rating

    A+

    87/100

  • Compensation

    D

    55/100

Learn more on Comparably

DNAnexus News and Updates

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data

DNAnexus, which provides a cloud platform for governments, universities, doctors, and pharmaceutical companies to tap into DNA and other clinical datasets and collaborate on scientific research projects, is today announcing a big step ahead in its efforts to grow its reach and purpose. The 10 year-o…

Sutter, UPMC and DNAnexus forge precision medicine partnership

The teams will collect, process and analyze EHR data of up to 3,000 patients to create personalized care plans for people with MS.

DNAnexus Blogs

The Hybrid Hackathons of the Future — now with Librarians!

Authors Hannah Gunderman, Data, Gaming, and Popular Culture Librarian, Carnegie Mellon University Libraries Ben Busby, Director, Solution Science and Principal Scientist, DNAnexus Introduction With the world still reckoning with the impacts of the COVID-19 pandemic, one thing that has remained const…

Better Together: Regeneron & HLI Share Their Experiences with DNAnexus & AWS

Polymerase and primers. VCF and TBI. DNAnexus and AWS. Some things are just better together. At DNAnexus, we are big believers in collaboration — among scientists, between industry and academia, and amid complementary technologies. Our platforms enable researchers to work together across geographica…

Visit us at Bio-IT World 2021!

We’re excited to see back in you person at Bio-IT World in Boston! We’ll be there, masked up, and ready to join fellow life sciences, clinical, healthcare, pharma, and IT professionals to discuss recent advancements in the field, and the future of precision medicine. Come to our talks and visit us i…

Computational Immunology: Tailoring Tools to Tackle the T-Cell Triad

Whether you’re a seasoned computational scientist or an armchair immunologist, the growing focus on the T-cell triad — MHC, peptide & TCR — in both infectious and chronic diseases is necessitating easy access to complex datasets and analysis tools that can make sense of the human adaptive immune…

How New Practices in Biomedical Research are Changing the Future of Healthcare

Five years ago, we were ushering in the ‘era of precision medicine,’ with researchers and clinicians alike embracing advances in genomics to help tailor treatments to individual patients, especially in cancer care.  How has biomedical research and clinical care changed since then, and what does the …

How Multi-Omics is Changing Biomedical Research

Genomics, transcriptomics, proteomics, metagenomics… biology now seems to revolve around the “omics.” What exactly are they, why are they so crucial, and where is the field heading? First off, a definition. When added to a biological word, “omics” refers to a global study of a system. So, for those …
Show more

DNAnexus Frequently Asked Questions

  • When was DNAnexus founded?

    DNAnexus was founded in 2009.

  • Who are DNAnexus key executives?

    DNAnexus's key executives are Richard Daly, George Asimenos and Julie Baher.

  • How many employees does DNAnexus have?

    DNAnexus has 187 employees.

  • Who are DNAnexus competitors?

    Competitors of DNAnexus include HistoGeneX, Lentigen and NIMGenetics.

  • Where is DNAnexus headquarters?

    DNAnexus headquarters is located at 1975 W El Camino Real, Mountain View.

  • Where are DNAnexus offices?

    DNAnexus has offices in Mountain View, Boston, San Francisco and Washington.

  • How many offices does DNAnexus have?

    DNAnexus has 4 offices.